Diabetes News Archive

A diagnosis of diabetes means lifestyle changes are in order, but where does one begin?

A Biodesign team of researchers, led by Randall Nelson, PhD, has received a new five-year, $3.1 million award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. Their goal is to discover and validate telltale molecular signs to learn how to predict who will develop the disease long before any symptoms of diabetes appear.

BELLUS Health announced today that it will discontinue its NC-503 diabetes development program following the results of the recently completed Phase IIa clinical proof-of-concept study evaluating NC-503 (eprodisate disodium) as a treatment for Type 2 diabetes. The study did not meet its primary efficacy endpoint.

Diabetes shouldn't be a reason to hold you back from things you love. And nobody knows that better than Rachel Gower, who is taking part in and raising money for the HBF Run for a Reason on May 23.

After five months of construction, Trinity`s new diabetes center is now open. Located in the Town and Country Shopping Center, the new center offers more office space, educational opportunities, and more support groups.

Racial disparities could result in life-threatening hypoglycemia and increased complicationsResearchers at LSU Health Sciences Center New Orleans and Children's Hospital of New Orleans have found that there is a major difference in the hemoglobin A1c (HbA1c) response to blood glucose between African-American and Caucasian children with diabetes.

Lots of concerns about managing diabetes

JAMA. 2010;303(17):1681-1683. Atlanta New research suggests that aggressively treating lipid levels and hypertension in certain patients with diabetes with the aim of preventing cardiovascular morbidity and mortality does no better in this regard than standard careand may even be harmful.

NEW YORK (GenomeWeb News) The Biodesign Institute at Arizona State University has won a $3.1 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to discover and validate protein biomarkers that could be used in predictive tests for type 2 diabetes.

The popular diabetes medication metformin works in different fashion than the current widely accepted view, according to a recent study. This new finding could lead to wider use of the drug -- particularly in people with cancer and diseases linked to TSC deficiency like tuberous sclerosis and lymphangioleiomyomatosis.

ELKHART -- Elkhart General Diabetes Support Group will present "Overcoming Barriers" at 7 p.m. Thursday in Auditorium B in the west wing of Elkhart General Hospital.

Researchers at LSU Health Sciences Center New Orleans and Children's Hospital of New Orleans have found that there is a major difference in the hemoglobin A1c (HbA1c) response to blood glucose between African-American and Caucasian children with diabetes. HbA1c is the main test used to monitor diabetes and guide treatment decisions. African-American children test significantly higher than ...

University of Cincinnati researchers have learned that a widely prescribed diabetes drug doesn't work the way they thought. And the discovery could open the door to using metformin to treat cancer, tuberous sclerosis complex and other diseases.

( University of Cincinnati Academic Health Center ) The popular diabetes medication metformin works in different fashion than the current widely accepted view. This new finding could lead to wider use of the drug -- particularly in people with cancer and diseases linked to TSC deficiency like tuberous sclerosis and lymphangioleiomyomatosis.

The popular diabetes medication metformin works in different fashion than the current widely accepted view. This new finding could lead to wider use of the drug -- particularly in people with cancer and diseases linked to TSC deficiency like tuberous sclerosis and lymphangioleiomyomatosis.

Researchers have found there is a major difference in the hemoglobin A1c response to blood glucose between African-American and Caucasian children with diabetes. African-Americans test significantly higher than Caucasians who have similar average blood glucose levels, misleading their doctors into believing that glucose levels are higher than they really are. If both tests aren't taken into ...

A recent study led by MedImpact Healthcare Systems, Inc., investigated a pilot Value-Based Benefit Design (VBBD) program to improve adherence to diabetes medications. The study found that a VBBD program that reduced copayments for diabetes medications by 36% reduced the number of non-adherent patients by 30%. The findings are significant because one of the most pressing challenges payors face ...

LSU Health Sciences Center New Orleans researchers found there is a major difference in the hemoglobin A1c response to blood glucose between African-American and Caucasian children with diabetes. African-Americans test significantly higher than Caucasians who have similar average blood glucose levels, misleading their doctors into believing that glucose levels are higher than they really are. If ...

( Louisiana State University Health Sciences Center ) LSU Health Sciences Center New Orleans researchers found there is a major difference in the hemoglobin A1c response to blood glucose between African-American and Caucasian children with diabetes. African-Americans test significantly higher than Caucasians who have similar average blood glucose levels, misleading their doctors into believing ...

Federal health regulators have warned that a class of prostate cancer drugs called Gonadotropin-Releasing Hormone (GnRH) agonists have been associated with a small increase in the risk of diabetes, heart attack and strokes. GnRH agonists are marketed under the brand names Eligard, Lupron, Synarel, Trelstar, Vantas, Viadur, and Zoladex. There are also [...]

( Arizona State University ) For the estimated 21 million people in the United States with type 2 diabetes and the 57 million more at risk of developing the illness, a new project at the Biodesign Institute at Arizona State University will address a critical need to develop technologies aimed at early detection. The research aims to improve outcomes for this increasingly common form of diabetes ...

A DEDICATED diabetes treatment centre has been built at St Peter's Hospital in memory of a Chertsey teenager who died eight years ago.

(ARA) - Diabetes affects more than 23 million people in the United States, with type 2 diabetes representing 90 to 95 percent of those cases, according to the Centers for Disease Control and Prevention (CDC). But the good news is that people with type 2 diabetes can find balance in their lives with a structured plan that includes proper nutrition and regular exercise.